Dr. Reddy's Generic Found Not To Infringe Lunesta Patent

Law360, New York (January 22, 2013, 1:56 PM EST) -- A New Jersey federal judge on Thursday found that Dr. Reddy’s Laboratories Ltd. didn’t infringe a patent belonging to Sunovion Pharmaceuticals Inc. for its blockbuster drug Lunesta, finding that Dr. Reddy’s proposed generic version of the sleep aid is chemically different.

U.S. District Judge Dennis M. Cavanaugh granted Dr. Reddy’s move for summary judgment of noninfringement as to U.S. Patent No. 6,444,673 over its planned drug, saying that the generic doesn’t fall within the scope of Sunovion’s asserted claims for the '673 patent.

At issue is...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.